Arkolith/Insider Trading/MIRM/Form 4

Peetz Christopher

CHIEF EXECUTIVE OFFICER, DirectorMirum Pharmaceuticals, Inc. (MIRM) · full profile →Form 4 · filed Mar 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.8M
Net Open-Market Flow
-$3.8M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Sell(S)41K$91.98$3.8M194K
Mar 15, 2026Option exercise(M)25K——185K
Mar 15, 2026Option exercise(M)50K——235K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 15, 2026Option exercise(M)25K—$00
Mar 15, 2026Option exercise(M)50K—$025K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001614740-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML